These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 17608847)
1. Survival predictors in patients with node-negative gastric carcinoma. Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847 [TBL] [Abstract][Full Text] [Related]
2. Significant prognostic factors in patients with early gastric cancer. Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H Int Surg; 2000; 85(4):286-90. PubMed ID: 11589593 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. Adachi Y; Mori M; Maehara Y; Kitano S; Sugimachi K J Am Coll Surg; 1997 Apr; 184(4):373-7. PubMed ID: 9100682 [TBL] [Abstract][Full Text] [Related]
4. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353 [TBL] [Abstract][Full Text] [Related]
5. Significant prognostic factors in patients with node-negative gastric cancer. Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813 [TBL] [Abstract][Full Text] [Related]
6. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878 [TBL] [Abstract][Full Text] [Related]
7. Is tumor size a prognostic indicator for gastric carcinoma? Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of lymphatic invasion in patients with node-negative gastric cancer. Ichikawa D; Kubota T; Kikuchi S; Fujiwara H; Konishi H; Tsujiura M; Ikoma H; Nakanishi M; Okamoto K; Sakakura C; Ochiai T; Kokuba Y; Otsuji E J Surg Oncol; 2009 Aug; 100(2):111-4. PubMed ID: 19475584 [TBL] [Abstract][Full Text] [Related]
9. Biologic predictors of survival in node-negative gastric cancer. Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579 [TBL] [Abstract][Full Text] [Related]
10. Impact of lymphovascular invasion in patients with stage I gastric cancer. Kunisaki C; Makino H; Kimura J; Takagawa R; Kosaka T; Ono HA; Akiyama H; Fukushima T; Nagahori Y; Takahashi M Surgery; 2010 Feb; 147(2):204-11. PubMed ID: 19878963 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer. Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552 [TBL] [Abstract][Full Text] [Related]
12. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339 [TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Dicken BJ; Saunders LD; Jhangri GS; de Gara C; Cass C; Andrews S; Hamilton SM Ann Surg Oncol; 2004 Jun; 11(6):629-35. PubMed ID: 15150070 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection. Bilici A; Seker M; Ustaalioglu BB; Kefeli U; Yildirim E; Yavuzer D; Aydin FM; Salepci T; Oncel M; Gumus M Ann Surg Oncol; 2010 Aug; 17(8):2037-44. PubMed ID: 20333555 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464 [TBL] [Abstract][Full Text] [Related]
17. Multivariate prognostic study on large gastric cancer. Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596 [TBL] [Abstract][Full Text] [Related]
18. Predictive factors for lymph node metastasis in early gastric cancer with submucosal invasion: analysis of a single institutional experience. An JY; Baik YH; Choi MG; Noh JH; Sohn TS; Kim S Ann Surg; 2007 Nov; 246(5):749-53. PubMed ID: 17968165 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107 [TBL] [Abstract][Full Text] [Related]
20. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection. Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]